[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:fallopian-tube-neoplasm":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Fallopian Tube Neoplasm",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07213804","A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer",[11],"Phase 3","RECRUITING","2026-08-26T02:17:27.435233Z","2026-07-05T05:32:16.660912Z",[],[]]